Sanofi SA

SAN: XPAR (FRA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|W&LOCK|@cyfLOCK|n!v!k%

Sanofi's New Leadership Faces Looming Patent Cliff

Business Strategy and Outlook

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline creates strong cash flows and a narrow economic moat.

Sponsor Center